Cucchetti A, Serenari M, Sposito C, Di Sandro S, et al. Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant. J Hepatol 2020 Mar 19. pii: S0168-8278(20)30177.
PMID: 32201284